Stem cell therapy for mild to moderate COPD
Part of Lungs & breathing clinical trials.
This study tests whether a new type of stem cell (SMS cells) can help people with mild or moderate COPD caused by smoking or pollution. You will receive the treatment by inhalation and be followed to see if your breathing improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 39 and 69 years old.
- You have mild or moderate COPD (from smoking or pollution) and have been treated for it before.
- Your COPD has been stable for at least 12 weeks (no flare-ups or hospital stays) and you have not changed your COPD medications in the last 28 days.
- You agree not to smoke or vape during the study, and you must be willing to follow the study schedule.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
This trial tests a new stem cell therapy for people with moderate to severe COPD who have not improved with standard treatments. The goal is to see if the therapy is safe and can help improve lung function.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests whether transplanting a patient's own lung stem cells can improve lung function in people with chronic obstructive pulmonary disease (COPD). It aims to see if this treatment is safe and helps repair damaged lung tissue.
This trial is testing a new type of cell therapy called REGEND007 for people with COPD. It looks at whether the treatment can help improve how far you can walk and your overall breathing.
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
Hear when a new Chronic Obstructive Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.